Table 10.6b

Immunosuppression Used for Maintenance Prior to Discharge, 1994 to 2003

Recipients with Intestine Transplants

		Year of Transplant
		1994	1995	1996	1997	1998	1999	2000	2001	2002	2003
Functioning Graft at Discharge		16	33	35	47	48	49	60	88	89	103
With Immunosuppression Info		16	31	24	46	48	49	60	88	89	103
Corticosteroids	Category Usage	100.0%	93.5%	100.0%	97.8%	97.9%	93.9%	96.7%	79.5%	64.0%	67.0%
	Steroids	100.0%	93.5%	100.0%	97.8%	97.9%	93.9%	96.7%	79.5%	64.0%	67.0%
Cyclosporine	Category Usage	6.3%	6.5%	0.0%	2.2%	8.3%	4.1%	0.0%	0.0%	0.0%	1.0%
	Cyclosporin	6.3%	6.5%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
	Sandimmmune	0.0%	0.0%	0.0%	0.0%	4.2%	0.0%	0.0%	0.0%	0.0%	0.0%
	Neoral	0.0%	0.0%	0.0%	2.2%	4.2%	4.1%	0.0%	0.0%	0.0%	1.0%
Tacrolimus	Category Usage	75.0%	93.5%	91.7%	95.7%	89.6%	95.9%	95.0%	98.9%	95.5%	93.2%
	FK506	75.0%	93.5%	91.7%	95.7%	89.6%	95.9%	95.0%	98.9%	95.5%	93.2%
Antimetabolites	Category Usage	25.0%	32.3%	58.3%	54.3%	35.4%	24.5%	21.7%	10.2%	12.4%	8.7%
	Azathioprine	25.0%	22.6%	20.8%	10.9%	6.3%	6.1%	6.7%	6.8%	0.0%	0.0%
	Mycophenolate mofetil	0.0%	6.5%	37.5%	45.7%	33.3%	18.4%	18.3%	3.4%	12.4%	8.7%
	Cytoxan	0.0%	6.5%	8.3%	4.3%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Other	Category Usage	0.0%	0.0%	0.0%	0.0%	0.0%	2.0%	40.0%	21.6%	19.1%	5.8%
	Rapamycin	0.0%	0.0%	0.0%	0.0%	0.0%	2.0%	40.0%	21.6%	19.1%	5.8%

Source: OPTN/SRTR Data as of May 3, 2004.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may

be prescribed more than one drug within the same category.